Isatuximab-mediated CDC was only observed in MM and DLBCL cell lines with high CD38 receptor density and low surface densities of the CDC inhibitors CD46, CD55, and CD59. The gene discussed is CD59; the disease is diffuse large B-cell lymphoma.